MRNA vs NBTB · rev $145.0M vs P/E 14, rev $368.4M
Moderna Inc (MRNA) versus NBT Bancorp Inc (NBTB) — a side-by-side from cached financials, not a winner call.
Moderna Inc (MRNA) is a biotechnology company listed on NASDAQ. It is led by Stéphane Bancel M.B.A..
NBT Bancorp Inc (NBTB) is a banks - regional company listed on US.
Latest reported MRNA revenue for 2026-06-30 was $145.0M. Net income was -$782.0M. Revenue was down 62.7% from 2026-03-31 to 2026-06-30. MRNA currently screens at market cap $24.52B.
Latest reported NBTB revenue for 2026-06-30 was $368.4M. Net income was $104.2M. NBTB currently screens at market cap $2.29B and trailing P/E 14.4.
MRNA currently screens at market cap $24.52B. NBTB currently screens at market cap $2.29B and trailing P/E 14.4.
Not investment advice. Open the MRNA and NBTB stock pages for the full models.
Not investment advice.